IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 112

Article Submitted : 17407

Article Published : 7574

Total Authors : 20108

Total Reviewer : 733

Total Countries : 134

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Clinicopathological profile and Pre-treatment staging of primary lung cancer - A bispective cohart study.
Authors Name: Dr Rajat Agarwal , Dr Rajesh Agrawal , Dr Rushikesh Katakam , Dr Mohd Javed Khan , Dr Rishi Kumar Saini
Download E-Certificate: Download
Author Reg. ID:
IJRTI_190436
Published Paper Id: IJRTI2411001
Published In: Volume 9 Issue 11, November-2024
DOI:
Abstract: Background: The current global statistics for the year 2022 indicate that there were almost 20million new cases of cancer and close to 10million cancer deaths. With almost 2.5million new cases and over 1.8million deaths worldwide lung cancer is the leading cause of cancer morbidity and mortality in 2022 ,responsible for close to one in eight(12.4%)cancers diagnosed globally and one in five (18.7%)cancer deaths. The disease ranks first among men and second among women for both incidence and mortality, with male‐to‐female lung cancer incidence and mortality ratios of around.1 Compared to the western population, the prevalence of lung cancer in India appears to be increasing.2 • AIM: To study clinicopathological profile and pre-treatment staging of lung cancer. • OBJECTIVES: The specific objectives of the studies were as follows: • To evaluate clinical profile of patients who were diagnosed with lung cancer. • To study the histology of lung cancer. • To stage the lung cancer at the time of presentation. Methodology: This present study was carried out at the Respiratory Medicine Department of Rohilkhand Medical College and Hospital in Bareilly, Uttar Pradesh. Chief complaints were noted and detailed history along with clinical examination was done. 1.USG/ CT-Guided fine-needle aspiration (FNAC) or biopsy from site of lesion as per feasibility Fiber optic Bronchoscopy and BAL (Bronchoalveolar lavage) or biopsy, pleural fluid analysis, peripheral lymph node biopsy, thoracoscopy guided biopsy or biopsy from any other site for definitive diagnosis. 2. Fine needle aspiration cytology /histopathology of relavent sample was done 3. Pathological molecular cytology characteristics of the tumor was analysed as and when required Results: In our study, the investigation modalities used diagnose lung cancer were precisely depending on the site of lesion. Ultrasound guided transthoracic procedures gave diagnosis in 52% of cases whereas fibreoptic bronchoscopy assisted procedures in 48% patients.. When correlating the diagnostic modalities used with site of lesion, significant positive correlation exists between them (significant >0.05, p value: 0.000). In the present study, two third of patients had advanced disease (stage IIIB-IV) at the time of presentation. Nearly 50% of them were with poor performance status. This was due to wrong conception about symptoms, neglecting early symptoms, occasionally psychological reasons such as denial of illness are some of the cause for delay in seeking medical help for the confirmation and treatment of cancer. This emphasizes the need to create awareness among general population about lung cancer. Nearly 50% of the advanced disease patients have poor performance status. This was mainly due to disease severity and partly due to level of tobacco exposure. The performance status was directly correlated to smoking index in our study.
Keywords: : Pre-treatment staging and primary lung cancer
Cite Article: "Clinicopathological profile and Pre-treatment staging of primary lung cancer - A bispective cohart study.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 11, page no.1 - 5, November-2024, Available :http://www.ijrti.org/papers/IJRTI2411001.pdf
Downloads: 000205076
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2411001
Registration ID:190436
Published In: Volume 9 Issue 11, November-2024
DOI (Digital Object Identifier):
Page No: 1 - 5
Country: Bareilly, Uttarpradesh, India
Research Area: Medical Science
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2411001
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2411001
Share Article:

Share Facebook Twitter Google+ Pinterest LinkedIn Email Tumblr WhatsApp Google Gmail

Click Here to Download This Article

Article Preview
Click Here to Download This Article
Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300
IJRTI

WhatsApp
Click Here

Indexing Partner
Copyright © 2025 - All Rights Reserved - IJRTI